• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Harrison's Manual of Oncology

Harrison's Manual of Oncology

9780071411899
428,34 zł
406,92 zł Zniżka 21,42 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 406,92 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
The full spectrum of oncology medications -- backed by the authority of Harrisons!

From todays leading clinicians in cancer care comes this comprehensive yet portable guide to the major chemotherapeutic and supportive care agents in oncology. Full of never-before-published content, this invaluable clinical companion features numerous tables and a concise, outline-oriented text, making it ideal for reference at a glance.

Features::::
  • A complete overview of all medications used in cancer care, including hormonal agents and biologic response modifiers
  • Tables and templated format clearly highlight each drug and its companion regimen
  • Clinically relevant and prescriptive approach emphasizes precise dosing regimens and potential combinations for tailoring multi-drug regimens
  • Section on supportive and palliative care
  • A review of high-dose therapy and bone marrow transplant
  • Content that goes beyond the treatment of primary or metastatic disease to encompass the treatment of all therapeutic complications
Szczegóły produktu
42813
9780071422899
9780071411899

Opis

Rok wydania
2008
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
624
Wymiary (mm)
119 x 211
Waga (g)
560
  • Contributors
    Preface
    Acknowledgments
    Introduction to Cancer Pharmacology, Bruce A. Chabner
    Section 1:: Classes of Drugs
    1. Antimetabolites:: Fluoropyrimidines and Other Agents, Bruce A. Chabner
    2. Antifolates, Bruce A. Chabner
    3. The Taxanes and Their Derivatives, Hamza Mujagic and Bruce A. Chabner
    4. Vinca Alkaloids, Bruce A. Chabner
    5. Topoisomerase Inhibitors:: Camptothecins, Anthracyclines, and Etoposide, Dan Zuckerman and Bruce A. Chabner
    6. Adduct-Forming Agents:: Alkylating Agents and Platinum Analogs, Bruce A. Chabner
    7. Thalidomide and Its Analogs, Hamza Mujagic
    8. Bleomycin, Bruce A. Chabner
    9. L-Asparaginase, Bruce A. Chabner
    10. Molecular Targeted Drugs, Jeffrey W. Clark
    11. Differentiating Agents, Bruce A. Chabner
    Section 2:: Hormonal Agents
    12. Hormonal Agents:: Antiestrogens, Kathrin Strasser-Weippl and Paul E. Goss
    13. Antiandrogen Therapy, Bruce A. Chabner
    Section 3:: Biologic Response Modifiers
    14. Interferons, Dan L. Longo
    15. Cytokines, Growth Factors, and Immune-Based Interventions, Dan L. Longo
    16. Monoclonal Antibodies in Cancer Treatment, Dan L. Longo
    Section 4:: Supportive Care
    17. Bisphosphonates, Matthew R. Smith
    18. Febrile Neutropenia, Mark C. Poznansky and Fabrizio Vianello
    19. Anemia, James E. Bradner
    20. Cancer and Coaguloapthy, Rachel P.G. Rosovsky
    21. Metabolic Emergencies in Oncology, Elizabeth Trice and Ephraim Paul Hochberg
    22. Pain Management, Juliet Jacobsen and Vicki Jackson
    23. Comprehensive End-of-Life Care, Jennifer Temel
    24. Depression, Anxiety, and Fatigue, William F. Pirl
    25. Respiratory Emergencies, Tracey Evans
    Section 5:: Myeloid Malignancies
    26. Myeloid Malignancies, Karen Ballen
    Section 6:: Lymphoid Malignancies
    27. Hodgkins Disease, Dan L. Longo
    28. Non-Hodgkins Lymphoma, Yi-Bin Chen and Ephraim Paul Hochberg
    29. Acute Lymphoblastic Leukemia and Lymphoma, Eyal C. Attar and Janet E. Murphy
    30. Chronic Lymphocytic Leukemia, Philip C. Amrein
    31. Plasma Cell Disorders, Noopur Raje and Dan L. Longo
    Section 7:: Myelodysplastic Syndromes
    32. Myelodysplastic Syndromes, Eyal C. Attar
    Section 8:: Myeloproliferative Syndromes
    33. Polycythemia Vera, Jerry L. Spivak
    34. Idiopathic Myelofibrosis, Jerry L. Spivak
    35. Essential Thrombocytosis, Jerry L. Spivak
    Section 9:: High-Dose Therapy and Bone Marrow Transplant
    36. High-Dose Chemotherapy, Yi-Bin Chen
    37. Bone Marrow Transplantation, Thomas R. Spitzer
    Section 10:: GU Oncology
    38. Renal Cell Carcinoma, Abraham B. Schwarzberg and M. Dror Michaelson
    39. Localized Prostate Cancers, John J. Coen and Douglas M. Dahl
    40. Testicular Cancer, Timothy Gilligan
    41. Bladder Cancer, Donald S. Kaufman
    42. Advanced Prostate Cancer, Matthew R. Smith
    Section 11:: GI Oncology
    43. Esophageal Cancer, Geoffrey Liu
    44. Gastric Cancer, Lawrence S. Blaszkowsky
    45. Pancreative Cancer, Jeffrey W. Clark
    46. Hepatocellular Carcinoma, Andrew X. Zhu
    47. Cholangiocarcinoma and Gallbladder Cancers, Andrew X. Zhu
    48. Colon Cancer, David P. Ryan
    49. Rectal Cancer, Brian M. Alexander and Theodore S. Hong
    50. Anal Cancer, Johanna Bendell
    Section 13:: Thoracic Oncology
    51. Malignant Mesothelioma, Pasi A. J?e
    52. Non-Small Cell Lung Cancer, Lecia V. Sequist
    53. Review of Clinical Trials in Thymoma, Panos Fidias
    54. Small Cell Lung Cancer, Rebecca Suk Heist
    Section 13:: Gyn Oncology
    55. Ovarian Cancer, Richard T. Penson
    56. Primary Squamous Carcinoma of the Uterine Cervix:: Diagnosis and Management, Marcela G. del Carmen
    57. Uterine Cancer, Carolyn Krasner
    Section 14:: Breast Oncology
    58. Breast Oncology:: Clinical Presentation and Genetics, Tessa Cigler and Paula D. Ryan
    59. Localized Breast Cancer, Beverly Moy
    60. Metastatic Breast Cancer, Steven J. Isakoff and Paula D. Ryan
    Section 15:: Melanoma
    61. Melanoma, Donald P. Lawrence and Krista M. RubinSection 16:: Sarcoma
    62. Soft Tissue and Bone Sarcomas, Sam S. Yoon, Francis J. Hornicek, David C. Harmon, and Thomas F. DeLaney
    Section 17:: Neuro-Oncology
    63. Primary Brain Tumors, Andrew S. Chi and Tracy T. Batchelor
    64. Metastatic Brain Tumors, April F. Eichler and Scott R. Plotkin
    65. Paraneoplastic Neurologic Syndromes, Kathryn J. Ruddy and Fred H. Hochberg
    Section 18:: Head and Neck Cancer
    66. Head and Neck Cancer, John R. Clark, Paul M. Busse, and Daniel Deschler
    Index
Komentarze (0)